In particular, we focused our attention on two subtypes of the glutamate receptor—NMDA (1, 2A, and 2B) and the neurotrophin BDNF, which play a critical role in mediating cognitive functions that are impaired in schizophrenia [34,35,36,37]. This evidence concerns the gene BDNF and schizophrenia.